AllyGPO Celebrates Silver Stevie Award Win
AllyGPO®, a prominent leader in drug purchasing for specialty practices, has recently been awarded the Silver Stevie® Award for Technical Innovation of the Year in Healthcare Technology at the 2026 Stevie Awards. This accolade commends organizations globally that are shaping the future of technology across various sectors. Over 700 nominations from numerous organizations worldwide were considered in this year's competition, highlighting AllyGPO's commitment to innovation.
The award was granted for AllyIQ®, a cutting-edge platform powered by artificial intelligence that drastically enhances drug management, inventory oversight, and predictive analytics for community oncology and retina practices. These are among the most significant financial burdens on such practices, operating on a 'buy-and-bill' model, where they purchase drugs in anticipation of insurance reimbursement.
AllyIQ is distinguished by its extensive capabilities, featuring over 12 million lines of code and leveraging multiple AI algorithms to facilitate effective drug contracting and inventory management. Specifically tailored for independent specialty practices, AllyIQ provides decision-makers with real-time insights into their purchasing and management processes, thus improving financial outcomes and operational efficiency.
Brian Ansay, CEO of AllyGPO, expressed pride in receiving this prestigious recognition. He emphasized that enabling independent practices to have better control over drug costs and inventory ultimately supports their sustainability and ability to provide continuous care in their communities.
Supporting Independent Practices
A significant shift in the U.S. healthcare landscape has led to the consolidation of independent practices under large health systems, which can restrict physician autonomy and choices in care delivery. AllyGPO's mission counters this trend by offering solutions aimed at preserving the operational independence of oncology and retina practices. By providing them with the right tools, practices can maintain financial stability and prioritize patient-centered care.
AllyIQ employs advanced technologies, including computer vision and machine learning, to help practices streamline drug procurement and improve operational workflows. The results are impressive: a reported 75% reduction in drug ordering time, 99% accuracy in audits, faster rebate payments by 35 days, and a 10% decrease in inventory holding days. These efficiencies are invaluable for practices striving to sustain their margins.
AllyGPO's Ongoing Commitment to Innovation
In addition to its recent Stevie Award recognition, AllyGPO was also featured in Fast Company's 2026 list of Best Workplaces for Innovators, further underscoring its dedication to fostering an innovative workplace culture. This environment empowers employees and positions the organization to continue delivering transformative solutions in the rapidly evolving pharmaceutical landscape.
Headquartered in Frisco, Texas, AllyGPO aims to equip community-based specialty practices with the necessary tools to navigate the complexities of the drug market effectively. By merging intelligent inventory management with extensive drug contracting services, AllyGPO not only enhances the sustainability of practices but also ensures better healthcare outcomes for patients. To learn more about AllyGPO and its offerings, visit
www.AllyGPO.com.
Conclusion
The 2026 Stevie Awards not only celebrated the outstanding achievements of AllyGPO but also recognized the potential of technology to dramatically change healthcare practices. As more entities strive to innovate and improve operational efficiencies, AllyGPO’s achievements serve as a beacon of progress in the healthcare industry, proving that smart technology integration can lead to better care for patients and sustainability for practices.
To view the complete list of the 2026 Stevie Award winners, including those in the Healthcare Technology category, check the official Stevie Awards website for further insights into this year's groundbreaking innovations.